Globe Newswire Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 12, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Revenue from...\n more…
Zacks Investment Research A month has gone by since the last earnings report for Catalyst Pharmaceutical (CPRX). Shares have added about 8.3% in that time frame, outperforming the S&P 500.Will the recent positive trend...\n more…
Zacks Investment Research For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and...\n more…
Simply Wall St We wouldn't blame Catalyst Pharmaceuticals, Inc. ( NASDAQ:CPRX ) shareholders if they were a little worried about the...\n more…
Globe Newswire CORAL GABLES, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing...\n more…
Zacks Investment Research For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and...\n more…